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Background: Chronic neuropathic pain is a neuro-immune disorder, characterised by allodynia, hyperalgesia and
spontaneous pain, as well as debilitating affective-motivational disturbances (e.g., reduced social interactions, sleep-wake
cycle disruption, anhedonia, and depression). The role of the immune system in altered sensation following nerve injury
is well documented. However, its role in the development of affective-motivational disturbances remains largely
unknown. Here, we aimed to characterise changes in the immune response at peripheral and spinal sites in a rat model
of neuropathic pain and disability.
Methods: Sixty-two rats underwent sciatic nerve chronic constriction injury (CCI) and were characterised as either Pain
and disability, Pain and transient disability or Pain alone on the basis of sensory threshold testing and changes in post-CCI
dominance behaviour in resident-intruder interactions. Nerve ultrastructure was assessed and the number of T
lymphocytes and macrophages were quantified at the site of injury on day six post-CCI. ATF3 expression was quantified
in the dorsal root ganglia (DRG). Using a multiplex assay, eight cytokines were quantified in the sciatic nerve, DRG and
spinal cord.
Results: All CCI rats displayed equal levels of mechanical allodynia, structural nerve damage, and reorganisation. All CCI
rats had significant infiltration of macrophages and T lymphocytes to both the injury site and the DRG. Pain and disability
rats had significantly greater numbers of T lymphocytes. CCI increased IL-6 and MCP-1 in the sciatic nerve. Examination
of disability subgroups revealed increases in IL-6 and MCP-1 were restricted to Pain and disability rats. Conversely, CCI led
to a decrease in IL-17, which was restricted to Pain and transient disability and Pain alone rats. CCI significantly increased
IL-6 and MCP-1 in the DRG, with IL-6 restricted to Pain and disability rats. CCI rats had increased IL-1β, IL-6 and MCP-1 in
the spinal cord. Amongst subgroups, only Pain and disability rats had increased IL-1β.
Conclusions: This study has defined individual differences in the immune response at peripheral and spinal sites
following CCI in rats. These changes correlated with the degree of disability. Our data suggest that individual immune
signatures play a significant role in the different behavioural trajectories following nerve injury, and in some cases may
lead to persistent affective-motivational disturbances.
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It is now widely accepted that neuropathic pain is a neuro-
immune disorder [1, 2]. Through their inflammatory me-
diators, immune and immune-like glial cells are able to
directly activate and sensitise nociceptors, thereby increas-
ing their excitability and contributing to central sensitisa-
tion in the dorsal horn of the spinal cord [1, 3, 4]. A major
focus of research into the neuro-immune bases of pain has
been the sensory-discriminative aspects of neuropathic
pain (i.e. allodynia, hyperalgesia and spontaneous pain),
primarily at peripheral and spinal cord sites. However, a
role for the immune system in mediating the debilitating
affective-motivational disturbances experienced by neuro-
pathic pain patients, such as reduced familial and social in-
teractions, sleep-wake cycle disruption, impaired cognition,
reduced physical activity, lack of motivation, anhedonia
and depression [5–17], are yet to be similarly investigated.
The idea that the immune system can regulate higher
order behaviours has recently begun to gain traction. In-
dividual differences in emotional coping styles are
reflected in differences in the interactions of the immune
system and the hypothalamic-pituitary-adrenal (HPA)
axis, for detailed review see [18]. Furthermore, the
neuro-immune interface may result in direct modulation
of complex behaviours. For example, cytokines of per-
ipheral origin act at multiple central nervous system
(CNS) sites to trigger acute sickness behaviours (charac-
terised by fatigue, reduced appetite and sleep-wake
changes), as well as modulating depression and cogni-
tion [19, 20]. Recently, it has been suggested that high
comorbidity of chronic pain and depression is indicative
of a common mechanism involving chronic inflamma-
tion [21]. This view is supported by a study in the olfac-
tory bulbectomised rat, where chronic treatment with
systemic minocycline attenuated both depressive-like be-
haviour and nerve injury-induced allodynia, whilst con-
comitantly increasing the expression of anti-inflammatory
markers in microglia of the prefrontal cortex [22]. There
is also a growing number of studies in rodent models of
neuropathic pain where peripheral nerve injury alone
leads to increases in pro-inflammatory cytokines (e.g.,
interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor ne-
crosis factor (TNF)) in pain-related brain regions: namely
the periaqueductal gray (PAG) [23, 24], hypothalamus
[24], hippocampus [25–29], prefrontal cortex [23, 27, 30, 31],
nucleus accumbens (NAcc) [32] and rostral ventromedial
medulla [33]. Furthermore, some of these studies have
demonstrated that nerve injury-induced pro-inflammatory
cytokine release in the brain is responsible for behavioural
changes, including memory deficits [29, 34], reduced
conditioned place-preference to morphine [32], and
depressive-like behaviour [23].
Work from our laboratory over a number of years has
shown consistently that sciatic nerve chronic constrictioninjury (CCI), a commonly used model of neuropathic pain,
triggers persistent changes in resident-intruder social in-
teractions in only a subgroup of rats (~30 %), termed Pain
and disability [35–40]. This subgroup of rats also exhibits
changes in sleep-wake cycle regulation and neuro-
endocrine disruptions in both HPA and hypothalamo-pi-
tuitary-thyroid axes [37, 41, 42]. Furthermore, we have
shown recently that a specific neuro-immune signature of
gene expression in the spinal cord characterises these Pain
and disability rats at both day two and day six following
CCI [43]. Despite only a subgroup of rats showing disabil-
ities, all CCI rats show equal levels of thermal and mech-
anical allodynia and hyperalgesia [1, 37]. Simply put,
sensory changes are decoupled from the expression of al-
tered social interactions, sleep-wake cycle disruption and
neuro-endocrine dysfunction.
The emerging appreciation of the importance of the
neuro-immune interface in: (i) regulating affective-mo-
tivational and cognitive function and; (ii) the expression
of the neuropathic pain state, raises the important ques-
tion of whether individual differences in the expression
of disabilities following nerve injury, as seen in the Pain
and disability rats, reflects distinct neuro-immune signa-
tures which can be detected in both the periphery and
the spinal cord. The experiments reported here are di-
rected at answering this question.
Outbred rats underwent CCI or sham surgery and
were characterised using the resident-intruder social in-
teractions paradigm for injury-induced disabilities prior
to the following: (i) structural quantification of the de-
gree of nerve damage following CCI by examining mye-
lin thickness, immunoreactivity of S100 (a Schwann cell
marker) and assessing the number of dorsal root ganglia
(DRG) neurons expressing the stress transcription factor,
activating transcription factor 3 (ATF3); (ii) quantifica-
tion of the number of both innate (macrophages) and
adaptive immune cells (T lymphocytes) present in the
sciatic nerve and DRG; and (iii) quantification of the
protein levels of several cytokines in the ipsilateral sci-
atic nerve, ipsilateral DRG and the L4-L5 spinal cord
segments. We found that Pain and disability rats had a
distinct immune response at both peripheral and spinal
cord sites compared to rats without disabilities, despite




All experimental procedures were carried out in accord-
ance with the guidelines of the NHMRC “Code for the
care and use of animals in research in Australia” and the
“Ethical guidelines for investigations of experimental pain
in conscious animals” laid down by the “International As-
sociation for the Study of Pain” [44]. Furthermore, the
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(AEC) approved all procedures (#AEC numbers 3176,
3920 and 4852). We also followed the ARRIVE guidelines
for “Animal Research: Reporting In Vivo Experiments”
(http://www.nc3rs.org.uk/arrive-guidelines). All proce-
dures were designed to minimise the intensity and dur-
ation of animal suffering as well as animal numbers,
within the context of addressing the experimental aims.
Experiments were performed on 82 outbred, male
Sprague–Dawley rats, (ARC, Australia) weighing 220–
320 g on the day of CCI. Rats were housed individually in
clear Perspex cages in an animal house maintained on a
reversed 12/12 h light/dark cycle (lights on at 1900 h) with
food and water available ad libitum. Behavioural analyses
were conducted during the dark phase of the circadian
cycle. Room temperature was maintained at 22 (±1) °C.“Resident-intruder” social interactions testing
The resident-intruder paradigm used in these studies
consisted of habituating the “resident” to its home-cage
for one week, before the introduction of an unfamiliar
sex, age and weight-matched “intruder” rat (see [37] for
complete details). Rats were randomly assigned as resi-
dents or intruders. Social interactions between residents
and intruders were analysed for six days before CCI,
followed by a further six days of testing after CCI (n = 62)
or sham surgery (n = 16). On the day of CCI, no behav-
ioural testing was conducted. Social interactions were
video recorded for 6 min at approximately the same time
during the dark phase each day. Resident rats never en-
countered the same intruder more than twice and never
on consecutive days throughout testing.
Chronic constriction injury of the sciatic nerve
Sciatic nerve CCI was performed in a manner identical
to that first described by Bennett and Xie [45]. Briefly,
anaesthesia was induced with 5 % halothane/isoflurane
in 100 % O2 (Lyppard, Castle Hill, NSW, Australia) and
maintained during surgery via a custom made facemask
(2 % in 100 % O2). The right sciatic nerve was exposed
by blunt dissection through the biceps femoris and four
ligatures (chromic gut, 5.0, Johnson & Johnson Medical,
North Ryde, NSW, Australia) were loosely tied, 1 mm
apart, just proximal to the trifurcation of the sciatic
nerve. Constriction was minimal to cause “visible retard-
ation, but not arrest, of the epineural vasculature” as ori-
ginally defined [45]. Sham rats had the sciatic nerve
exposed but not ligated. The incision was sutured (Mer-
silk, 5.0, Johnson & Johnson Medical, North Ryde, NSW,
Australia) and iodine solution (Povidone-Iodine, Orion
Laboratories, Balcatta, WA, Australia) and triple anti-
biotic powder (Tricin, Sigma-Aldrich, Castle Hill, NSW,
Australia) were applied topically. Each rat was observedclosely during its recovery period and during the 24 h
following its return to the home-cage.
Behavioural analyses
Resident behaviour during the 6 min test period was
quantified within four mutually exclusive categories.
Dominance behaviour: standing on top of the supine in-
truder, back or lateral attack with biting targeted at the
neck or back of the intruder and chasing the intruder.
Social behaviour: investigation or sniffing of intruder
with particular focus on anogenital region. Non-social
behaviour: cage exploration and self-grooming. Submis-
sive behaviour: defensive alerting/freezing and defensive
sideway or supine posture upon the approach of the in-
truder. These categories were identical to those used
previously [37].
Development of stable resident-intruder interactions
requires prior intruder exposure. Therefore, the behav-
iour of each resident on the post-CCI days was com-
pared with its behaviour on the three days immediately
prior to CCI (i.e. pre-CCI days 4–6) once stable interac-
tions had been established. Resident rats were then cate-
gorised into three subgroups, based upon changes in the
duration of dominance behaviour post-CCI, in keeping
with previous studies: (i) Pain alone (n = 24): no change
in the duration of dominance behaviour post-CCI, com-
pared to pre-CCI; (ii) Pain and disability (n = 19): a re-
duction of at least 30 % in the duration of dominance
behaviour on at least 5 out of 6 post-CCI days, com-
pared to pre-CCI days; and (iii) Pain and transient dis-
ability (n = 19): an initial transient reduction of at least
30 % in the duration of dominance behaviour on the first
3–4 days post-CCI, compared to pre-CCI, followed by a
return to pre-CCI levels (days 4/5–6).
Mechanical withdrawal threshold testing
Testing was conducted in the dark phase under red
light, at least 1 h after resident-intruder interactions.
Rats were habituated to the behavioural testing appar-
atus for at least 30 min before data collection. Three
baseline pain behaviour measurements were made prior
to nerve injury, as well as two post-injury time-points
(post-CCI day 2/3 or 4/5). Sensitivity to mechanical
stimuli was assessed using a dynamic plantar von Frey
anesthesiometer (Ugo Basile, Varese, Italy). The von Frey
filament was applied to the mid-plantar surface, and the
mechanical withdrawal threshold (in grams) of each
hind-paw was calculated as the mean of five trials. The
interval between trials on the same paw was at least
5 min.
Immunohistochemistry
Immediately following resident-intruder testing on day
6, 14-19 rats per behavioural group and 11 shams were
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Lethabarb, 120 mg/kg, Lyppard) and perfused transcar-
dially with heparinised 0.9 % saline, followed by 4 % para-
formaldehyde in acetate-borate buffer (pH 9.6; 4 °C). The
sciatic nerve and L4 DRG were removed and post-fixed
for 1 h before being cryoprotected in 30 % sucrose in
PBS (pH 7.4), with 0.05 % sodium azide, and stored at
4 °C. Tissues were cryosectioned, with the sciatic nerve
cut longitudinally (14 μm) and the DRG cut coronally
(10 μm). Ten series of sections were collected onto
slides at intervals of 1 in 10, with slides stored at −20 °C
until use. Staining was performed directly onto the
slides, with the sections first washed in 100 % ethanol
for 10 min. Sections were then twice rinsed in distilled
water, before one wash in PBS. For T cell receptor αβ
(TCRαβ) staining, an additional 3 min incubation with
acetone was followed by three PBS washes. The sections
were blocked for 30 min in PBS containing 0.05 %
Tween-20 and 5 % normal horse serum (NHS) (Sigma-
Aldrich, Castle Hill, NSW, Australia). Sciatic nerve and
DRG sections were stained for T lymphocytes with
mouse-anti-rat TCRαβ (1:250, clone R73, BD Bioscience,
North Ryde, NSW, Australia) and for macrophages with
mouse-anti-rat CD68 (1:250, clone ED1, Serotec, distrib-
uted by Abacus ALS, Meadowbrook, QLD, Australia) in
PBS containing 5 % bovine serum albumin (BSA) and
0.05 % Tween-20 for 2 h at room temperature. Addition-
ally, sciatic nerves were stained with rabbit-anti-rat-S100
(1:500, Sigma-Aldrich, Castle Hill, NSW, Australia), a
Schwann cell structural protein, also in PBS containing
5 % BSA and 0.05 % Tween-20 for 2 h at room
temperature. The DRG were stained with rabbit-anti-rat-
ATF3 (1:500, Santa Cruz Biotechnology, Santa Cruz,
CA, USA) in 5 % NHS with 0.15 % Triton-X for 16 h.
Following primary incubations, sections were rinsed
three times in PBS and then incubated with Alexa488
conjugated donkey anti-mouse (1:100, Jackson, West
Grove, PA, USA) or Cy3 conjugated donkey anti-rabbit
(1:500, Jackson, West Grove, PA, USA) for 1 h in the
same buffer as the primary antibody. The sections were
then washed three times in PBS before being cover-
slipped with fluorescent mounting medium with DAPI
(Dako, North Sydney, NSW, Australia).Image analysis An investigator blinded to the behav-
ioural group of each rat undertook all image analyses.
Sections were viewed on a fluorescence microscope (BX51,
Olympus, Tokyo, Japan) and images captured using a digital
camera (DP70, Olympus, Tokyo, Japan). Multiple images
were taken from random fields of view, on each of four or
five sections from each rat. The images were non-
overlapping and entirely within the boundary of the nerve
or in areas of the DRG containing >90 % cell bodies.TCRαβ and ED1 immunoreactivity (IR) in injured sci-
atic nerves was quantified from 12 images captured at
the site of injury (i.e. the fields of view in the 1 mm be-
tween two chromic gut sutures and within 1 mm of the
most proximal and distal sutures). Images from an iden-
tical anatomical position, with respect to the sciatic
nerve trifurcation, were also captured from the sham
rats.
Immune cells (i.e. TCRαβ + T lymphocytes in sciatic
nerves and DRG and ED1-IR macrophages in the DRG)
or neuronal nuclei (i.e. ATF3-IR in the DRG) were
counted manually using the ImageJ cell counter plug-in
(NIH, Bethesda, MD, USA). TCRαβ + and ED1+ cell
counts were given as cells per mm2, adjusted from total
area sampled from 12 images, and the size of the field of
view using a × 40 objective lens. ATF3-IR neuronal nu-
clei were expressed as a percentage of total neurons
counted across ten images, thus normalising for different
numbers of neurons counted. However, a minimum
number of 300 neurons were assessed for each rat.
Where cell numbers were numerous (i.e. ED1 in the
nerve) or individual cells overlapped and continuous cell
borders could not be distinguished (i.e. S100 in the
nerve), densitometry analysis was performed using Ima-
geJ. A normalisation process was used for densitometry
measurements. The brightness and contrast setting in
ImageJ were set to standardise the levels of the back-
ground and the image was converted to a 16-bit black-
and-white image, so that the auto-threshold function
could be applied to the images prior to measuring the
%IR area. For ED1, the mean densitometry measure-
ments were calculated from 12 images per rat. For S100-
IR, the reduction in staining at the injury site was
assessed by comparing eight images captured within
1 mm of the injury site to eight images captured 4 mm
proximal to the injury site where no damage was evi-
dent. Thus, the mean %IR at the site of injury was di-
vided by the %IR at the uninjured proximal site to
calculate S100-IR ratio. In the sham rats, images of S100
were taken at identical anatomical positions within the
nerve in order to create a comparison S100-IR ratio.
Electron microscopy
Five rats from both Pain alone and Pain and disability
groups, as well as four control nerves from uninjured
rats were used for electron microscopy. Immediately fol-
lowing resident-intruder testing on day six, rats were
deeply anaesthetised with sodium pentobarbitone (i.p.,
Lethabarb, 120 mg/kg) and perfused transcardially with
heparinised 0.9 % saline. A 2.0-cm span of sciatic nerve
was freshly dissected from each rat and placed in
Karnovsky’s fixative solution (2.5 % glutaraldehyde, 2 %
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4) for
1 h. Nerves were post-fixed in 2 % osmium tetroxide for
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nerve was cut which was exactly 1 mm proximal to the
most proximal ligature. Nerve sections were dehydrated
in an ascending series of alcohol before embedding.
Nerves were placed in a 1:1 mixture of Spurr’s resin and
100 % ethanol and incubated for 1 h on a rotating plat-
form. The solution was replaced with 100 % Spurr’s resin
and incubated on the rotator overnight. The nerves were
transferred to small tubes to act as moulds, which were
filled up with Spurr’s resin and transferred to an oven at
65 °C to polymerise overnight. Embedded nerves were
sectioned at 70 nm on an ultra-microtome from a pos-
ition 1 mm proximal to the injury site before being
mounted onto support grids for imaging.
For each rat, ten randomly selected non-overlapping
fields of view were captured at × 1200 magnification
using a transmission electron microscope (JEM-1011,
Jeol, Tokyo, Japan) and digital camera (Orius 833, Gatan,
Pittsburgh, PA, USA). A second investigator blinded to
the behavioural groups of the rats undertook manual
analysis of images. Measurements of myelin thickness
from 100 axons across the ten images were taken, and a
mean thickness was calculated. Axons of all classes (Aα,
Aβ and Aδ) were selected for measurement if they inter-
sected with an equatorial line. The total number of
axons per 70 μm2 field of view was counted and a mean
calculated across the ten images for an individual rat.
Multiplex cytokine assays
Tissue preparation On post injury day seven, 4–5 rats
per group were deeply anaesthetised with sodium pento-
barbitone (i.p., Lethabarb, 120 mg/kg) and perfused with
heparinised 0.9 % saline. The injured sciatic nerve, its
L4 and L5 DRG, and segments L4-L5 of the spinal cord
(ipsilateral and contralateral to the injury) were dis-
sected, snap frozen in liquid nitrogen, and then stored
at −80 °C.
Tissue was homogenised using a total protein extrac-
tion kit (Merck Millipore, Bayswater, VIC, Australia)
consisting of 1× protease inhibitors in TM buffer
(HEPES, MgCl2, KCl, EDTA, sucrose, glycerol, sodium
deoxycholate, NP-40, sodium orthovanadate). TM buffer,
2.5 ml per gram of tissue, was added in two batches,
each followed by 5 min incubation on ice. Homogenising
beads (5 mm, stainless steel; Qiagen, Melbourne, VIC,
Australia) were used to mechanically disrupt samples
using a TissueLyser LT (Qiagen, Hilden, Germany) at
50 Hz for 20 s, repeated 6–8 times until fully homoge-
nised. Tissue homogenates were mixed at 4 °C for
20 min before centrifugation at 11,000 rpm at 4 °C for
20 min. The supernatant was isolated from the pellet
before a second centrifugation to obtain a completely
clear supernatant. The supernatant was assayed for totalprotein concentration using an EZQ Protein Quantification
kit (Invitrogen, Mount Waverley, VIC, Australia) according
to the manufacturer’s instructions. Protein samples were
stored at −20 °C until cytokine assay.
Running the multiplex cytokine assays Custom-made
multiplex cytokine assays (Bio-Plex Pro Rat 8-plex, Bio-
Rad Laboratories, Gladesville, NSW, Australia) were
used, according to the manufacturer’s instructions, to
determine the concentration of IL-1β, IL-6, IL-10, IL-
17A, IL-18, TNF, IFN-γ and MCP-1 in each of the ho-
mogenates collected. Briefly, tissue homogenates were
thawed on ice and standardised to 1600 μg/mL, diluting
in TM buffer. Samples were mixed 1:2 with sample dilu-
ent to bring the concentration to 800 μg/mL, and kept
at 4°C until used. To start the assay, 50 μl of vortexed
magnetic microbeads were added to each well. Beads
were then washed twice with Bio-Plex Pro wash buffer
using a magnetic plate washer (Tecan HydroFlex,
Crailsheim, Germany). Fifty microliters of standards and
samples were vortexed and added to the wells. Plates
were then sealed and kept in the dark, before being in-
cubated at room temperature for 1 h with agitation on a
plate mixer. Plates were washed three times and 25 μl of
vortexed detection antibodies were added to each well
prior to 30 min incubation. Plates were washed three
times and 60 μl of vortexed streptavidin-phycoerythrin
reporter (SA-PE) was added to each well, before incuba-
tion for 10 min. Next, plates were washed three times
before adding 125 μl assay buffer to each well. Plates
were then sealed and stored at 4 °C until acquisition.
Data were collected using a Bio-Plex 100 suspension
array system (Bio-Rad Laboratories, Gladesville, NSW,
Australia). Calibration kits were run before reading each
plate. Plates were agitated at 1100 rpm for 30 s prior to
reading. Standard curves were optimised and sample
cytokine concentrations determined using Bio-Plex
Manager software (v6.0 Bio-Rad Laboratories, Glades-
ville, NSW, Australia).
Statistical analysis
All data are presented as group means (±SEM). The ef-
fects of time and post-injury behavioural group on dom-
inance and non-social behaviours were analysed using a
two-way ANOVA with Bonferroni post hoc comparisons,
between each of the behavioural groups and shams. For
all electron microscope and immunohistological mea-
surements, an omnibus one-way ANOVA with Bonfer-
roni post hoc comparisons was used to compare all
groups. For cytokine expression levels, sham rats were
compared to the CCI rats using a one-way ANOVA. A
second test on the cytokine expression levels used an
omnibus one-way ANOVA with Bonferroni post hoc
comparisons between each behavioural subgroup and
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using linear regression to determine significant relation-
ships between changes in dominance and changes in
mechanical withdrawal threshold with: (i) ATF3-IR cells;
(ii) TCRαβ-IR; (iii) ED1-IR; and (vi) cytokine expression
levels, in each of the neural tissues collected. Only where
statistically significant correlations occurred are the data
shown (i.e. Fig. 5f ). All other correlations were not sta-
tistically significant. For all statistical analyses, family-
wise error rate was corrected using the Benjamini-Hoch-
berg procedure, with a false discovery rate of q <0.05 to
identify significance. A “family of analyses” was consid-
ered to be where the same biological material was used
for a group of independent analyses (i.e. analyses of
multiplex cytokine data conducted using the same tissue
sample or analyses of multiple immunohistochemistry
analyses conducted on the same nerve or DRG).Results
CCI triggers three distinct patterns of altered social
interactions
Consistent with our previous findings, three distinct pat-
terns of behaviour emerged following CCI. Twenty-four
residents were classified in the Pain alone group, main-
taining dominance behaviours towards the intruder after
CCI. Nineteen of the residents were classified in the
Pain and disability group, that is, they displayed a sig-
nificant reduction (>30 %) in the duration of dominance
behaviours on at least 5 post-CCI days. The remaining
19 residents were classified in the Pain and transient
disability group, displaying a transient and significant re-
duction (~30 %) in the duration of dominance on days
1–3 post-CCI, after which dominance behaviour
returned to pre-injury levels on days 4–6 after CCI.
Figure 1a, b shows the trajectories of dominance and
non-social behaviours, respectively, in each behav-
ioural group following CCI. There was a significant re-
duction in dominance behaviour in the Pain and
disability rats compared to Pain alone rats on days 3–
6 post-CCI (P <0.001), which was mirrored by a signifi-
cant increase in non-social behaviour (P <0.001). On
post-CCI days 1–3, the Pain and transient disability
group had a significant reduction in dominance behav-
iour (P <0.01–0.001) and an increase in non-social be-
haviour (P <0.05–0.01) compared to Pain alone,
although their behaviour returned to pre-injury levels
by days five and six post-CCI.
Figure 1c shows the mean reduction in mechanical
withdrawal thresholds in the injured hind-paw at two
time-points post-CCI. In keeping with our previous ob-
servations, all behavioural groups show a significant re-
duction in paw withdrawal threshold compared to
shams. Thus, the expression of behavioural disabilitydoes not relate to the degree of mechanical allodynia in-
duced by CCI.
CCI-induced structural changes are equal in all CCI
disability groups
Ultrastructural changes in the injured nerve were
assessed using transmission electron microscopy, 1 mm
proximal to the site of sciatic nerve ligation, in rats with
or without behavioural disability on day six post-CCI.
Uninjured nerves have tightly packed axons of a uniform
cross-sectional morphology (Fig. 2a). In contrast, injured
nerves have visible oedematous spaces between axons,
as well as axons with abnormal ruffled and blebbed
morphology (Fig. 2b, c). Although after CCI the number
of axons does not significantly decrease (Fig. 2d), myelin
thickness is significantly reduced in both Pain alone and
Pain and disability rats (Fig. 2e, P <0.05). Therefore, the
extent of structural change in axons located proximal to
the injury site did not differ between the two disability
groups assessed.
Using S100, a marker for Schwann cells, the extent of
demyelination at the site of ligation was investigated six
days after CCI. In sham rats, intense S100-IR shows
Schwann cells encapsulating axons, appearing as hollow
tubes, arranged closely in a uniform direction (Fig. 3a).
In all CCI rats at the site of ligation, morphological dif-
ferences in Schwann cells were detected; the cells
showed a granular appearance and disorderly arrange-
ment, accompanied by a large reduction in S100-IR
(Fig. 3b–d). The degree of loss of Schwann cells was
quantified by comparing S100-IR at the site of nerve in-
jury to an uninjured site located more proximally, thus
creating an S100-IR ratio. In sham rats, this ratio was
approximately 1, as the nerves displayed intense S100
along their length. However, in CCI rats of all behav-
ioural groups, this ratio was less than 1 and was signifi-
cantly different to the shams (Fig. 3i, P <0.001). Thus,
the extent of the loss of Schwann cells and resulting de-
myelination appears similar in rats from each of the
three disability groups.
Using the transcription factor ATF3, a marker of cellu-
lar stress, damage to individual neurons in the DRG was
investigated six days after CCI. In sham rats there were
very few DRG neurons that contained ATF3-IR nuclei
(Fig. 3e). In contrast, many ATF3-IR nuclei were seen in
the DRG of rats after CCI (Fig. 3f–h). The percentage of
ATF-IR cells was significantly increased in rats with Pain
and disability (P <0.05) and Pain alone (P <0.01) com-
pared to shams. Due to high variance in the Pain and
transient disability group, there was no significant differ-
ence compared to shams, although the mean of 15.2 ±
6.4 % was greater than the other CCI groups (Pain alone,
13.7 ± 2.1 % and Pain and disability, 9.8 ± 0.55 %) and
shams (2.3 ± 0.95 %) (Fig. 3j). There was no relationship
Fig. 1 The duration of a dominance and b non-social behaviours
during daily resident-intruder social interactions in sham controls
or rats classified as having Pain alone, Pain and disability and Pain
and transient disability six days after CCI (n = 16–24 per group). c The
reduction in mechanical withdrawal threshold in the injured hind-
paw, compared to the pre-CCI baseline, at two time-points (days 2–3
and days 4–5) after CCI. Statistically significant differences in social
interactions are indicated by *P <0.05, **P <0.01 and ***P <0.001, with
black asterisk indicating differences between sham vs. Pain and
disability, brown asterisk Pain alone vs. Pain and disability, pink asterisk
indicating Pain alone vs. Pain and transient disability and blue asterisk
indicating Pain and disability vs. Pain and transient disability. Significant
differences in withdrawal threshold compared to shams are indicated
by *P <0.05 and **P <0.01 for Pain and disability, #P <0.05 and ##P <0.01
for Pain alone, and ^^P <0.01 for Pain and transient disability
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tion in dominance behaviour or withdrawal thresholds
after CCI; it is unlikely therefore to be directly related to
the expression of either allodynia or disability.
CCI induces a robust immune response in the peripheral
nervous system, which is greatest in Pain and disability
rats
Using the macrophage marker ED1, the number of cells
infiltrating the injured sciatic nerve and its L4 DRG were
assessed six days after CCI. In the nerves of sham rats,
there was almost no ED1-IR (Fig. 4a). At the site of sci-
atic nerve injury dense ED1-IR was seen, indicative of
surface staining of infiltrating macrophages (Fig. 4b–d).
After CCI, quantification of the percentage ED1-IR at
the injury site revealed significant increases in rats with
Pain and disability (6.79 ± 0.9 %, P <0.001), Pain alone
(5.0 ± 0.6 %, P <0.001) and Pain and transient disability
(5.6 ± 0.9 %, P <0.001) compared to shams (0.23 ± 0.04 %,
Fig. 4e). The number of ED1-IR cells in the L4 DRG of
CCI rats (33 ± 3.9 cells per mm2) was greater than in
sham rats (11 ± 3.0 per mm2). However, this difference
reached significance in only the Pain and transient dis-
ability rats (P <0.05) (Fig. 4f). Thus, a large number of
macrophages infiltrate both the sciatic nerve and its L4
DRG after CCI, with the highest number in the Pain
and disability rats (sciatic nerve), and Pain and transient
disability rats (DRG).
Using T cell receptor αβ-IR (TCRαβ-IR), the number
of T lymphocytes infiltrating the injured sciatic nerve
and DRG were assessed six days after CCI. In the nerves
of sham rats, there was almost no TCRαβ-IR (Fig. 5a).
However, there was significant TCRαβ-IR visible on the
surface of cells at the site of sciatic nerve injury, indica-
tive of infiltrating T lymphocytes (Fig. 5b–d). Counts of
individual cells expressing TCRαβ within the injury site
revealed significant increases in rats with Pain and dis-
ability (41.6 ± 7.4 cells/mm2, P <0.001), Pain alone (21.1
Fig. 3 Representative immunoreactivity (IR) of the Schwann cell marker, S100, at the site of sciatic nerve injury in a sham, b Pain and disability, c
Pain and transient disability and d Pain alone rats on day six after CCI. Scale bars represent 50 μm. Representative ATF3-IR, a marker of cellular stress,
in the ipsilateral L4 DRG neurons in e sham, f Pain and disability, g Pain and transient disability and h Pain alone rats on day six after CCI.
Arrowheads indicate ATF-IR nuclei. Scale bars represent 50 μm. i The ratio of S100-IR at the site of injury compared to an uninjured site following
CCI (n = 11–14 per group). j The percentage of neurons with ATF3-IR nuclei compared to the total neurons counted in the ipsilateral L4 DRG after
CCI (n = 4–7 per group). Significant differences compared to sham controls are indicated by *P <0.05 and ***P <0.001 for Pain and disability, ##P <0.01
and ###P <0.001 for Pain alone, and ^^^P <0.001 for Pain and transient disability. All significant differences have been corrected for family-wise error rate
with the Benjamini-Hochberg procedure, with a false discovery rate of q <0.05
Fig. 2 Representative electron micrographs of axons located 1 mm proximal to the injury site six days after CCI from a uninjured, b Pain and
disability and c Pain alone rats. Scale bars represent 2 μm. d The mean axon count per 70 μm2 field of view, and e The mean myelin thickness of
100 axons from uninjured controls (n = 4), as well as from Pain alone and Pain and disability rats (n = 5 per group). Significant differences
compared to uninjured controls are indicated by *P <0.05 for Pain and disability and #P <0.05 for Pain alone
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Fig. 4 Representative ED1-IR, a macrophage marker, at the site of sciatic nerve injury in a sham, b Pain and disability, c Pain and transient disability
and d Pain alone rats on day six after CCI. Scale bars represent 20 μm. e The percentage of ED1-IR (of total area) at the site of nerve injury after
CCI (n = 9–13 per group). Scale bars represent 20 μm. f The number of ED1-IR cells per mm2 in the ipsilateral L4 DRG after CCI (n = 4–8 per group).
Significant differences compared to sham controls are indicated by **P <0.01 for Pain and disability, #P <0.05 for Pain alone, and ^P <0.05 and ^^P <0.01
for Pain and transient disability. All significant differences have been corrected for family-wise error rate with the Benjamini-Hochberg procedure, with a
false discovery rate of q <0.05
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ity (24.6 ± 3.6 cells/mm2, P <0.05) compared to shams
(1.4 ± 0.6 cells/mm2, Fig. 5e). However, there were also
significantly more T lymphocytes in Pain and disabil-
ity rats compared to Pain alone rats (P <0.01). A linear
regression analysis revealed a significant positive rela-
tionship between the number of T lymphocytes at the
injury site and the percentage change in dominance
after CCI (Fig. 5f, r2 = 0.32). After CCI, T lymphocyte
counts were significantly increased in the L4 DRG of
rats with Pain and disability (P <0.01), Pain alone (P
<0.05) and Pain and transient disability (P <0.05)
(Fig. 5g). There was no significant relationship between
the number of T lymphocytes in the L4 DRG and the
percentage change in dominance after CCI (Fig. 5h).
Thus, the number of T lymphocytes infiltrating the in-
jured nerve, but not the DRG, in response to CCI is
positively correlated with the expression of disability.
The protein expression of a panel of six pro-inflamma-
tory cytokines (IL-1β, IL-6, IL-17A, IL-18, TNF, IFN-γ),
the chemokine, MCP-1 and the anti-inflammatory cyto-
kine, IL-10, were assessed using a multiplex assay in the
sciatic nerve seven days after CCI (Table 1). CCI trig-
gered a massive increase in IL-1β, which exceeded the
sensitivity of the assay. Further, the levels of IFN-γ were
below the threshold for detection in sham-injured rats but
were reliably detected in all behavioural groups following
CCI. IL-6 and MCP-1 were significantly increased in CCI
rats compared to sham rats (P <0.05 and P <0.001,respectively). Conversely, IL-17A was significantly de-
creased in CCI compared to sham (P <0.001). Looking at
the disability subgroups, the Pain and disability group
was the only group to have a significant increase in IL-6
(151.8 ± 33.9 pg/ml) compared to sham rats (19.1 ± 3.4 pg/
ml, P <0.01). Moreover, the concentration of IL-6 in this
group was approximately two-fold greater than rats with
Pain alone (82.5 ± 20.2 pg/ml) and Pain and transient dis-
ability (61.4 ± 13.1 pg/ml). MCP-1 expression was increased
in only the Pain and disability group (546.8 ± 55.2 pg/ml)
compared to shams (151.2 ± 42.7 pg/ml, P <0.001). CCI
triggered a select decrease in sciatic nerve IL-17A in rats
without persistent disability, that is, Pain and transient dis-
ability and Pain alone rats compared to sham (P < 0.01 and
P <0.05, respectively). These data indicate a substantial pro-
inflammatory cytokine response in the sciatic nerve seven
days after CCI, with Pain and disability rats showing an in-
crease in IL-6 and MCP-1, and Pain and transient disability
and Pain alone rats showing a decrease in IL-17A.
The protein expression of the same panel of cytokines
was assessed in the L4 and L5 DRG ipsilateral to the in-
jury seven days after CCI (Table 2). IL-6 and MCP-1
were significantly increased in CCI rats compared to
sham rats (both P <0.001). Comparing the disability sub-
groups, IL-6 expression was significantly increased in
only Pain and disability rats (90.2 ± 9.9 pg/ml, P <0.001)
compared to sham rats (35.7 ± 6.8 pg/ml). MCP-1 ex-
pression was significantly increased in both Pain and
disability (152.1 ± 21.9 pg/ml, P <0.01) and Pain alone
Fig. 5 Representative TCRαβ-IR, a T lymphocyte marker, at the site of sciatic nerve injury in a sham, b Pain and disability, c Pain and transient
disability and d Pain alone rats on day six after CCI. Scale bars represent 20 μm. e The number of T lymphocytes per mm2 at the site of nerve
injury after CCI (n = 9–14 per group). f The relationship between T lymphocytes in the sciatic nerve and the percentage change in dominance
(from pre-CCI days 4–6 to post-CCI days 4–6) after CCI, in 33 rats. g The number of T lymphocytes per mm2 in the ipsilateral L4 DRG after CCI (n = 4–8
per group). h The relationship between the number of T lymphocytes in the ipsilateral L4 DRG and the percentage change in dominance (from pre-
CCI days 4–6 to post-CCI days 4–6) after CCI, in 17 rats. Significant differences compared to sham controls are indicated by **P <0.01 and ***P <0.001
for Pain and disability, #P <0.05 for Pain alone and ^P <0.05 for Pain and transient disability. Significant difference between Pain and disability and Pain
alone is indicated by ∝P <0.05. All significant differences have been corrected for family-wise error rate with the Benjamini-Hochberg procedure, with a
false discovery rate of q <0.05
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(83.1 ± 4.0 pg/ml). These data show a pro-inflammatory
response in the DRG after CCI, which is strongest in
Pain and disability rats.
CCI induces increased cytokine release in the spinal cord,
with Pain and disability rats showing the highest cytokine
levels
Cytokine expression was examined in whole L4-L5
spinal cord segments seven days after CCI (Table 3). IL-
1β, IL-6 and MCP-1 were all significantly increased in
CCI rats compared to sham rats (P <0.001, P <0.05 and
P <0.05, respectively). Within disability subgroups, only
IL-1β was increased selectively in Pain and disability
(143.6 ± 9.3 pg/ml, P <0.01) compared to sham rats
(88.3 ± 5.8 pg/ml). Therefore, CCI induces a pro-inflam-
matory response in sciatic nerve recipient segments ofthe spinal cord, which is more pronounced in the Pain
and disability group.
Discussion
This study characterised individual differences in the
immune response at peripheral and spinal sites follow-
ing CCI in rats. Whilst all CCI rats have significant in-
filtration of macrophages and T lymphocytes into
both the injury site and the DRG, it is the Pain and
disability rats that have the greatest number of both
cell types. Furthermore, Pain and disability rats have
select increases in IL-6 and MCP-1 in the sciatic nerve
and IL-6 in the DRG. All rats have an increase in IL-
1β, IL-6 and MCP-1 in the spinal cord. However, only
Pain and disability rats have a significant increase in
spinal IL-1β. These observations lead us to suggest
that individual immune signatures play a significant
Table 1 Mean cytokine concentration (pg/mL) (±SEM) in the ipsilateral sciatic nerve seven days following CCI
Cytokine Sham (n = 5) Combined CCI (n = 14) Pain and disability (n = 5) Pain and transient disability (n = 4) Pain alone (n = 5)
IL-1β 73.4 ± 8.2 >3860 >3860 >3860 >3860
IL-6 19.1 ± 3.4 101.2 ± 16.6* 151.8 ± 33.9** 61.4 ± 13.1 82.5 ± 20.2
IL-10 189.2 ± 36.2 162.4 ± 16.1 135.6 ± 19.4 157.0 ± 26.0 168.7 ± 10.8
IL-17A 55.7 ± 1.6 35.2 ± 2.4*** 37.9 ± 3.4 30.3 ± 5.0** 36.4 ± 4.4*
IL-18 77.8 ± 7.1 71.1 ± 2.6 73.2 ± 6.1 67.6 ± 3.5 71.6 ± 4.1
TNF 19.5 ± 1.2 77.6 ± 12.1* 96.0 ± 26.3 61.2 ± 8.3 72.4 ± 23.4
IFN-γ <5 33.5 ± 3.8 35.9 ± 9.1 34.0 ± 0.6 31.3 ± 5.4
MCP-1 151.2 ± 42.7 440.2 ± 34.1*** 546.8 ± 55.2*** 367.9 ± 45.3 391.5 ± 51.5
Statistically significant differences compared to sham are indicated by *P <0.05, **P <0.01 and ***P <0.001. All significant differences have been corrected for
family-wise error rate with the Benjamini-Hochberg procedure, with a false discovery rate of q <0.05
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CCI, and in some cases may lead to persistent behav-
ioural disabilities.Differential behavioural disabilities, despite near identical
sensory abnormalities and structural damage after CCI
In keeping with our published studies [35–42, 46], we
have established that three entirely different responses in
resident-intruder social interactions occur following sciatic
nerve CCI, with the Pain and disability group displaying a
persistent reduction in dominance behaviour. A reduction
in dominance behaviour is concomitant with increased
non-social behaviour as well as repetitive approach-avoid
behaviour, indicative of a heightened “risk-assessment”
coupled with an uncertainty of appropriate action [47, 48].
Despite this, all rats display similar mechanical allodynia,
again consistent with our previous findings [35, 37].
To determine whether the expression of disability sim-
ply reflected differences in the degree of physical damage
to the sciatic nerve, we examined the ultrastructure of in-
jured sciatic nerves using transmission electron microscopy
in representative animals at the extremes of the resident-
intruder behavioural continuum. Rats whose dominance
behaviour was completely unaffected by CCI were com-
pared with rats whose dominance behaviours were dramat-
ically reduced by the injury procedure. The overall finding
was that the degree of physical damage was not sufficient
to explain these differences in social interactions; we found
that an equal reduction in myelin thickness 1 mm from the
injury site occurs in both Pain and disability and Pain
alone rats. Similarly, an earlier study reported no structural
differences 1 cm proximal to the ligatures, whilst closer to
the injury (5 mm) there were signs of endoneurial oedema
and degeneration of some myelinated fibres ten days after
CCI [49]. Wallerian degeneration distal to the injury site is
severe, characterised by a profound loss of myelinated fi-
bres and large oedematous spaces [49]. We also observed
severe damage at distal sites, and therefore did not proceed
with quantitative analysis.As Wallerian degeneration proceeds, disintegration of
the myelin sheath occurs within 1–2 days at the site of
nerve injury [50]. Axonal damage can be examined using
the structural protein S100, which is preferentially distrib-
uted in myelin-forming Schwann cells [51]. Morphological
changes and a generalised decrease in the intensity of
S100-IR in all CCI rats six days post-injury is indicative of
severe demyelination and is consistent with previous stud-
ies that examined S100 after nerve injury [52, 53].
ATF3 has long been considered a marker of sensory
fibre damage, being rapidly expressed in almost all DRG
neurons following axotomy [54, 55]. The number of
ATF3 positive neurons in the L4 and L5 DRG of rats
after CCI has been reported to be around 20 % of total
neurons after 10–14 days [56, 57], which is broadly in
keeping with the 10–15 % reported here six days after
CCI. There was no significant difference between ATF3
positive neurons in Pain and disability rats and those
without ongoing disabilities (Pain alone and Pain and
transient disability). However, Pain and disability rats
had the fewest ATF3 cells, raising the possibility that
their injury was slightly less severe even though the re-
duced Schwann cell staining and myelin thickness do
not support this view. In summary, the three disability
groups displayed similar levels of mechanical allodynia
and were characterised by near identical damage and
structural re-organisation in both the injured nerve and
DRG. Thus, differences in behavioural disability defined
by altered social interactions are unlikely to be caused
by any inherent variability in the CCI procedure itself.
Differential patterns of immune response in the
peripheral nervous system
Peripheral cytokines Diffusible immune cytokines and
chemokines are released by resident immune (mast cells
and macrophages) and glial cells (Schwann and satellite
cells), as well as infiltrating immune cells (macrophages,
neutrophils, and T lymphocytes) at both the site of in-
jury and the DRG (for detailed review, see [1]). In animal
Table 2 Mean cytokine concentration (pg/mL) (±SEM) in the ipsilateral L4-L5 DRG seven days following CCI
Cytokine Sham (n = 5) Combined CCI (n = 14) Pain and disability (n = 5) Pain and transient disability (n = 4) Pain alone (n = 5)
IL-1β 65.3 ± 10.4 98.9 ± 8.8 102.1 ± 16.6 111.1 ± 24.9 86.0 ± 6.1
IL-6 35.7 ± 6.8 82.5 ± 4.7*** 90.2 ± 9.9*** 78.9 ± 12.4 77.5 ± 2.2
IL-10 255.4 ± 44.3 251.1 ± 18.0 217.2 ± 21.0 310.6 ± 34.2 237.4 ± 31.6
IL-17A 98.6 ± 17.0 89.0 ± 6.6 77.3 ± 5.0 106.7 ± 18.1 86.5 ± 10.6
IL-18 117.6 ± 13.6 108.1 ± 4.9 98.7 ± 6.9 123.5 ± 9.7 105.1 ± 7.5
TNF 30.0 ± 3.2 28.7 ± 1.3 27.4 ± 2.2 30.9 ± 2.8 28.3 ± 2.4
IFN-γ 47.1 ± 10.8 46.7 ± 4.9 42.2 ± 6.0 56.7 ± 13.6 43.1 ± 5.1
MCP-1 83.1 ± 4.0 149.0 ± 7.6*** 152.1 ± 21.9** 136.8 ± 7.8 155.4 ± 3.8**
Statistically significant differences compared to sham are indicated by *P <0.05, **P <0.01 and ***P <0.001. All significant differences have been corrected for
family-wise error rate with the Benjamini-Hochberg procedure, with a false discovery rate of q <0.05
Austin et al. Journal of Neuroinflammation  (2015) 12:96 Page 12 of 16models of neuropathic pain, these cells release the
archetypal pro-inflammatory cytokines, IL-1β, IL-6, TNF
and IFN-γ [2], as well as the more recently described IL-
17 [58, 59] and IL-18 [60, 61]. These cytokines are cap-
able of directly activating, or sensitising, primary afferent
nociceptors leading to allodynia and hyperalgesia (for
detailed reviews, see [1] and [2]). Furthermore, across
several nerve injury models displaying differential sen-
sory abnormalities (CCI, partial sciatic nerve ligation
and axotomy), allodynia was shown to correlate with the
numbers of ED1, IL-6 and TNF positive cells [62].
Therefore, it is clear that the immune system plays an
important role in the development of the sensory-dis-
criminative aspects pain.
Despite the wealth of knowledge surrounding the
role of cytokines in mediating sensory abnormalities in
models of nerve injury, few have evaluated their role in
the expression of affective-motivational disturbances.
In the current study, there were robust increases in IL-
1β and IFN-γ in the sciatic nerve of all CCI rats. How-
ever, given that the Pain and disability rats have the
highest number of macrophages and T lymphocytes, it
is perhaps unsurprising that this subgroup of rats had
highest levels of the pro-inflammatory cytokine IL-6 in
the sciatic nerve and DRG, since it is produced by both
cell types.Table 3 Mean cytokine concentration (pg/mL) (±SEM) in the L4-L5
Cytokine Sham (n = 5) Combined CCI (n = 14) Pain and disab
IL-1β 88.3 ± 5.8 129.2 ± 5.6*** 143.6 ± 9.3**
IL-6 58.8 ± 12.1 88.6 ± 4.7* 95.5 ± 7.1
IL-10 467.6 ± 54.3 559.4 ± 23.8 573.6 ± 19.8
IL-17A 277.5 ± 33.8 356.8 ± 21.4 409.7 ± 32.9
IL-18 104.0 ± 11.6 116.2 ± 5.5 112.2 ± 6.4
TNF 59.8 ± 2.9 66.6 ± 1.9 62.1 ± 1.6
IFN-γ 60.0 ± 11.2 66.44 ± 6.3 53.4 ± 9.0
MCP-1 111.7 ± 10.3 135.6 ± 3.5* 138.4 ± 4.5
Statistically significance differences compared to sham are indicated by *P <0.05, **
family-wise error rate with the Benjamini-Hochberg procedure, with a false discoverA recent study described preexisting individual differ-
ences in the peripheral immune system that predicted sus-
ceptibility or resilience to repeated social defeat stress.
Specifically, susceptible mice had elevated baseline plasma
IL-6, monocytes and T lymphocytes; whilst of the cyto-
kines upregulated by stress, IL-6 showed the greatest in-
crease [63]. This study raises the possibility that Pain and
disability rats have a preexisting elevation of plasma IL-6,
as well as circulating monocytes and T lymphocytes,
which explains the exaggerated immune response in per-
ipheral tissues after nerve injury and may also render this
subgroup susceptible to behavioural disability.
Elevated expression of the chemokine MCP-1 in the
sciatic nerve of Pain and disability rats may explain re-
cruitment of greatest number of immune cells in this
subgroup. MCP-1 is normally released by damaged
nerves and its mRNA is upregulated in the DRG neu-
rons after nerve injury [64]. This ultimately leads to the
recruitment of macrophages to the site of nerve injury
and the DRG, which are essential to phagocytose the
dead and dying remnants of damaged nerve fibres. How-
ever, MCP-1 release in the peripheral nervous system
(PNS) has previously been linked to the development of
sensory abnormalities [65]. A surprising finding was that
in the sciatic nerve increased levels of MCP-1 were re-
lated to the expression of disability.spinal cord segment seven days following CCI
ility (n = 5) Pain and transient disability (n = 4) Pain alone (n = 5)
116.8 ± 6.4 124.6 ± 10.4
92.3 ± 9.8 78.9 ± 8.3
579.1 ± 61.4 529.5 ± 50.3
351.0 ± 22.8 308.6 ± 42.7
127.8 ± 14.5 110.9 ± 9.3
70.2 ± 4.3 66.4 ± 3.7
65.3 ± 15.3 76.0 ± 9.0
135.9 ± 6.2 132.6 ± 8.4
P <0.01 and ***P <0.001. All significant differences have been corrected for
y rate of q <0.05
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culating cytokines, elevated plasma TNF levels have been
reported three and seven days after SNI [29]. Clinically,
peripheral blood mononuclear cells (PBMCs) collected
from chronic pain patients are primed to produce an ex-
aggerated immune response when stimulated with toll-
like receptor agonists [66]. Furthermore, patients with
painful neuropathy have increased serum expression of
TNF and IL-2 (a T cell activator), with the highest levels
of TNF found in patients with comorbid depression [67].
T lymphocytes Infiltration of T lymphocytes to the in-
jured sciatic nerve following CCI was first described by
Moalem-Taylor and colleagues, peaking 21 days after in-
jury [52]. It was further established that CD4+ helper T
lymphocytes of the Th1 subtype enhance pain hypersen-
sitivity, whilst those of the Th2 subtype attenuate sen-
sory abnormalities. Since then IL-17 positive CD4+ T
lymphocytes (Th17) cells have also been implicated in
contributing to pain hypersensitivity [59], whereas regu-
latory T lymphocytes (Tregs) have been shown reverse
mechanical allodynia in neuropathic animals [68, 69]. A
recent study in humans found a shift towards Tregs and
away from Th17 cells in the blood of neuropathic pain
patients compared to controls [70]. In light of the pre-
clinic findings, where Tregs were anti-nociceptive and
Th17 pro-nociceptive, the clinical findings were unex-
pected. However, whether the balance towards anti-
inflammatory Tregs in neuropathic pain patients repre-
sents an underlying pathophysiological mechanism, or is
an epiphenomenon, due to either an attempt to compen-
sate for ongoing inflammation, or immunosuppression
through the chronic stress of suffering from chronic
pain, remains to be determined. Further, the differences
between clinical and pre-clinical findings may in large
part be due to the different time-scales of neuropathy,
2–4 weeks in rodents [59, 68, 69] compared to months
to years clinically [70].
In the current study, there was no relationship be-
tween the number of T lymphocytes and allodynia, al-
though the level of disability was related to their
number. Using the widespread marker, TCRαβ, did not
allow examination of which T lymphocyte subset (CD8
or CD4 + Th1/Th2/Th17/Treg) predominated in the
nerves of Pain and disability rats, and this is certainly
an important question for future investigations.
To date, we are not aware of any studies that have re-
ported the impact of T lymphocytes on complex behav-
iours following nerve injury. However, adoptive transfer
of Th17 cells promoted depressive-like behaviour as well
as reducing social behaviour in mice, effects which could
be reversed by depleting Th17 or blocking IL-17A [71].
Interestingly, Pain and disability rats had no change in
sciatic nerve IL-17A, whereas Pain and transientdisability and Pain alone experienced a significant re-
duction in IL-17A, suggesting a possible reduction in
Th17 cells in the non-disabled groups, which may be re-
lated to maintenance of dominance behaviour.
There have been reports of T lymphocyte-dependent
coping behaviours in response to significant physical
stressors. Chronic restraint stress induces increased
serum levels of IL-6 and IL-1β in wild-type mice, whilst
mice lacking T-bet, a transcription factor necessary for
Th1 differentiation, were protected from these maladap-
tive responses [72]. More recently, depletion of Treg
cells in wild-type mice potentiated depressive-like and
anxiety-like behaviours, as well as serum IL-6 and TNF
levels following chronic restraint [73]. Furthermore, in
Treg-depleted mice, immobility in the forced swim test
positively correlated with the levels of peripheral cyto-
kines, but negatively correlated with the levels of 5-HT
in the hippocampus and dopamine in the prefrontal cor-
tex [73]. Thus, T lymphocytes have the capacity to
modulate depressive-like behaviour, as well as coping re-
sponses to physical stressors in mice, raising the possi-
bility of a similar role in the expression of pain and
disability in a subgroup of rats.
The elevated T lymphocytes in Pain and disability rats
are indicative of an enhanced adaptive immune response
in this subgroup. This could be in part due to a greater
adaptive response to the chromic gut itself, with en-
hanced sensitivity to the foreign antigens (bovine or
ovine intestines) or the chemical treatment (chromium
ions or pyrogallol). However, chromic gut is essential for
the reliable development of allodynia, as well as spinal
cord level central sensitisation, compared to silk sutures
that induced neither [74, 75].
Mechanisms for differential adaptive immune re-
sponses have been strongly linked with HPA axis activ-
ity. We have shown previously that CCI rats from all
behavioural groups have elevated plasma corticosterone
levels, peaking on day three [41]. It is also known that
rats with distinct emotional coping responses (proactive
versus reactive) show differences in HPA reactivity and
helper T lymphocyte polarisation in response to stressors
[76, 77]. Elevated glucocorticoids are thought to be anti-
inflammatory, shifting the balance of helper T lymphocytes
towards Th2 [78]. A glucocorticoid-mediated mechanism
may explain the shift towards Tregs in neuropathic pain
patients [70].
The basis of individual differences in the HPA-im-
mune relationship may well find an origin in early life;
for example, maternal separation led to a subpopulation
of mice developing glucocorticoid resistance of splenic
lymphocytes and hence an enhanced pro-inflammatory
cytokine response to subsequent immune challenges
[79]. It is tempting to speculate that lymphocyte resist-
ance to glucocorticoids develops in rats of the Pain and
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sponse (via loss of Th2), resulting in the expression of
disability. Further studies are required to investigate this
possibility.
Differential patterns of immune response in the central
nervous system
The dorsal horn of the spinal cord contains the first syn-
apse of the nociceptive pathway. Thus, there is a robust
activation of astrocytes and microglia [80, 81], as well as
infiltration of monocytes and T lymphocytes [82–84] in
response to mediators such as ATP and MCP-1 released
from damaged and hyperexcitable sensory nerve fibres
in the spinal cord following nerve injury. Activation of
these cell types induces release of cytokines such as IL-
1β, IL-6 and TNF in high concentrations [85]. This cre-
ates a positive loop of activation, since cytokines further
exacerbate glial activation and thereby potentiate their
own release. Cytokines and chemokines, such as MCP-1,
can act on neurons directly, modulating ascending nocicep-
tive pathways to exacerbate sensory abnormalities [1, 2] or
potentially modulate affective-motivational signalling. In-
deed, the role of neuro-immune interactions in driving Pain
and disability has been proposed in our recent study exam-
ining gene transcription in the spinal cord after CCI [43].
Of the 35 genes that were selectively regulated in Pain and
disability rats, approximately two-thirds (65 %) were genes
for protein involved in neurotransmission and inflamma-
tion (compared to only 34 % in rats without disability). In
particular, selective increases in mRNA for complement
component 3, ciliary neurotrophic factor (an IL-6-like cyto-
kine), prostaglandin receptor F and P2X2 receptors were
discovered in the spinal cord of Pain and disability rats, in-
dicating an exaggerated and unique immune signature in
these rats. These findings fit well with our current observa-
tions, where Pain and disability rats had a selective in-
crease in spinal cord IL-1β, whilst the expression levels of
IL-6 and MCP-1 were also highest in this subgroup of rats.
These immune mediators may well selectively modulate as-
cending pathways specific to the expression of disability.
Several studies have reported that GFAP (indicative of
astrocyte activation) and CD11b expression are in-
creased in the PAG following nerve injury [23, 24, 39].
Of particular relevance here, Pain and disability rats
have elevated GFAP in lateral and ventrolateral columns
of the PAG [39], which receive ascending projections
from the spinal cord and nucleus of the solitary tract,
and are critical in the regulation of specific behavioural
coping strategies [86]. Therefore, it is possible that dif-
ferences in the neuro-immune signature in the spinal
cords of Pain and disability rats selectively modulate as-
cending spinal-mesencephalic projections leading to the
specific pattern of GFAP expression seen in this subgroup,
consequently contributing to the expression of disability.Conclusions
This study is the first to characterise individual differ-
ences in immune response to CCI at peripheral and
spinal sites, despite the same degree of damage and sen-
sory abnormalities. These differential patterns of im-
mune response correlate with the degree of disability in
social interactions, with the Pain and disability sub-
group displaying a distinct pro-inflammatory signature.
Two recent clinical studies highlight the importance of
individual differences in the immune system in modulat-
ing functional recovery from injury. Firstly, using mass
spectrometry Gaudilliere and colleagues demonstrated
recovery from hip arthroplasty correlates with a specific
single-cell immune signature in monocytes [87]. Sec-
ondly, Schistad and colleagues demonstrated that high
serum IL-6 is associated with poor long-term (one year)
recovery from lumbar radicular pain [88]. Thus, distinct
immune signatures in individual rats at multiple levels
of the neuraxis in response to traumatic nerve injury
likely influence the trajectory of recovery from CCI, par-
ticularly the expression of behavioural disabilities. Sim-
ply put, an individual’s immune signature may on one
hand lead to functional recovery or on the other to the
development of persistent pain accompanied by debili-
tating changes in affective-motivational state.Abbreviations
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